BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10393217)

  • 1. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    J Lipid Res; 1999 Jul; 40(7):1317-27. PubMed ID: 10393217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
    Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
    Burnett JR; Telford DE; Barrett PH; Huff MW
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):10-8. PubMed ID: 16427354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
    Huff MW; Telford DE; Barrett PH; Billheimer JT; Gillies PJ
    Arterioscler Thromb; 1994 Sep; 14(9):1498-508. PubMed ID: 8068612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
    Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
    Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
    Wilcox LJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of the ACAT inhibitor avasimibe (CI-1011).
    Llaverías G; Laguna JC; Alegret M
    Cardiovasc Drug Rev; 2003; 21(1):33-50. PubMed ID: 12595916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat.
    Post SM; Zoeteweij JP; Bos MH; de Wit EC; Havinga R; Kuipers F; Princen HM
    Hepatology; 1999 Aug; 30(2):491-500. PubMed ID: 10421659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mevinolin and cholestyramine inhibit the direct synthesis of low density lipoprotein apolipoprotein B in miniature pigs.
    Huff MW; Telford DE; Woodcroft K; Strong WL
    J Lipid Res; 1985 Oct; 26(10):1175-86. PubMed ID: 3906004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
    Bocan TM; Krause BR; Rosebury WS; Mueller SB; Lu X; Dagle C; Major T; Lathia C; Lee H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):70-9. PubMed ID: 10634802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.
    Burnett JR; Wilcox LJ; Huff MW
    Clin Chim Acta; 1999 Aug; 286(1-2):231-42. PubMed ID: 10511295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic behavior of hepatic VLDL and plasma LDL apoB-100 in African green monkeys.
    Marzetta CA; Johnson FL; Zech LA; Foster DM; Rudel LL
    J Lipid Res; 1989 Mar; 30(3):357-70. PubMed ID: 2723543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity.
    Chan DC; Watts GF; Barrett PH; Mori TA; Beilin LJ; Redgrave TG
    J Clin Endocrinol Metab; 2002 May; 87(5):2283-9. PubMed ID: 11994377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ; Offerman EH; van Duyvenvoorde W; van Der Boom H; de Wit EC; Gijbels MJ; van Der Laarse A; Jukema JW; Havekes LM; Princen HM
    Circulation; 2001 Apr; 103(13):1778-86. PubMed ID: 11282910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
    Telford DE; Lipson SM; Barrett PH; Sutherland BG; Edwards JY; Aebi JD; Dehmlow H; Morand OH; Huff MW
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2608-14. PubMed ID: 16210564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
    Riches FM; Watts GF; Hua J; Stewart GR; Naoumova RP; Barrett PH
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2854-61. PubMed ID: 10443691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs.
    Huff MW; Telford DE; Barrett PH
    Arterioscler Thromb; 1992 Aug; 12(8):902-10. PubMed ID: 1637788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.